FDA Alert Articles

New Study Fails to Tie Antidepressant to Suicide in Kids

Tuesday, February 7th, 2012
A new analysis of clinical trial data has ...

Generic Zyprexa OK’d by FDA for Schizophrenia, Bipolar Disorder

Tuesday, October 25th, 2011
The U.S. Food and Drug Administration (FDA) on Monday approved the first generic versions of Zyprexa (olanzapine tablets) ...

Celexa Linked to Heart Damage at High Doses

Wednesday, August 24th, 2011
According to the U.S. Food and Drug Administration (FDA), the antidepressant Celexa (citalopram hydrobromide, which is also available as ...

Recall of Antipsychotics Risperdal, Risperidone Issued

Saturday, June 18th, 2011
Two popular antipsychotic medications made by Johnson & Johnson -- Risperdal and risperidone -- have been recalled due to possible contamination with a ...

Invega Approved as Treatment for Schizophrenia in Teens

Wednesday, April 13th, 2011
A new drug has been approved for a rare population -- teens with schizophrenia. The illness is typically diagnosed first in young ...

FDA Reviews Claims that Artificial Food Dyes Contribute to Hyperactive Behavior

Friday, April 1st, 2011
The U.S. Food and Drug Administration is currently reviewing recent studies of food coloring and its effect ...

Pfizer Issues Voluntary Recall of Citalopram and Finasteride

Monday, March 28th, 2011
The maker of Citalopram and Finasteride announced a voluntary recall of the two drugs Saturday due to mislabeling and possible ingestion of the wrong drug by patients. Greenstone LLC, a subsidiary of drug giant Pfizer, announced ...

Viibryd Approved to Treat Depression in Adults

Tuesday, January 25th, 2011
Viibryd (vilazodone hydrochloride) was approved by the U.S. Food and Drug Administration Monday to treat major depression -- also known as clinical ...

New Medication Approved for Schizophrenia

Monday, November 1st, 2010
The U.S. Food and Drug Administration has approved Latuda (lurasidone HCl) tablets for the treatment of adults with schizophrenia. ...

Latuda Approved to Treat Schizophrenia

Thursday, October 28th, 2010
On Thursday, the U.S. Food and Drug Administration today approved Latuda (lurasidone HCl) -- an atypical antipsychotic medication -- for the treatment of ...
Subscribe to Our Weekly Newsletter



Find a Therapist


Users Online: 5094
Join Us Now!